10.56 -0.47 (-4.32%)
CLDA
Stock Details
Last Trade:10.56 Change:-0.47 (-4.32%) Prev Close:11.03 Open: 10.88 Days Range:10.50 – 10.88 52 Week Range: 6.38 - 19.59 Volume:77556 P/E: N/AEPS:-5.63
View AllRecent Alerts 07/04/09
Recent Alert on 06/19/09 at 4:32pm
Clinical Data (CLDA) Receives Approval of Generic Name Vilazodone, New Class of Experimental Treatments for Depression
Clinical Data (CLDA) Receives Approval of Generic Name Vilazodone, New Class of Experimental Treatments for Depression
Clinical Data, Inc. (NASDAQ: CLDA) announced today that the United States Adopted Name Council (USAN) has approved the generic name vilazodone hydrochloride. Vilazodone, if approved, would represent a first-in-class drug for the treatment of... Read More
Recent Alert on 06/02/09 at 9:54am
Morning Movers 6/2: NAVR, HLND, DDUP, NTG Higher; EXFO, KAI, MOD, BCS, BKD, DAKT Lower
Morning Movers 6/2: NAVR, HLND, DDUP, NTG Higher; EXFO, KAI, MOD, BCS, BKD, DAKT Lower
Recent Alert on 06/02/09 at 8:55am
Clinical Data (CLDA) Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Clinical Data (CLDA) Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Recent Alert on 06/02/09 at 8:55am
Clinical Data (CLDA) Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Clinical Data (CLDA) Announces Positive Results from Second Phase III Trial of Vilazodone for Depression
Recent Alert on 05/28/09 at 4:11pm
Clinical Data (CLDA) Completes Acquisition of Avalon Pharmaceuticals
Clinical Data (CLDA) Completes Acquisition of Avalon Pharmaceuticals
View AllRecent Press Releases
No Recent Press Releases Available